Zura Bio Ltd. Files 8-K: Regulation FD & Financials
Ticker: ZURA · Form: 8-K · Filed: Sep 3, 2024 · CIK: 1855644
| Field | Detail |
|---|---|
| Company | Zura Bio Ltd (ZURA) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, regulation-fd
TL;DR
Zura Bio dropped an 8-K on Sept 3rd covering Reg FD and financials. Check it out.
AI Summary
Zura Bio Ltd. filed an 8-K on September 3, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly JATT Acquisition Corp, is incorporated in the Cayman Islands and operates in the biological products sector. Its principal executive offices are located in La Jolla, California.
Why It Matters
This filing provides crucial updates on Zura Bio's regulatory compliance and financial status, which are important for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K for financial statements and disclosures, not indicating any immediate operational or financial distress.
Key Numbers
- 001-40598 — Commission File Number (Identifies the company's SEC filing history)
- 98-1725736 — I.R.S. Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Zura Bio Ltd (company) — Registrant
- JATT Acquisition Corp (company) — Former company name
- Cayman Islands (jurisdiction) — Place of incorporation
- La Jolla, California (location) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet. Further review of the full filing would be required.
When was Zura Bio Ltd. formerly known as JATT Acquisition Corp?
The date of the name change from JATT Acquisition Corp to Zura Bio Ltd was April 7, 2021.
What is Zura Bio Ltd.'s Standard Industrial Classification (SIC) code?
Zura Bio Ltd.'s SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Where are Zura Bio Ltd.'s principal executive offices located?
The company's principal executive offices are located at 4225 Executive Square, Suite 600, La Jolla, CA 92037.
What is the fiscal year end for Zura Bio Ltd.?
Zura Bio Ltd.'s fiscal year ends on December 31st.
Filing Stats: 571 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-09-03 06:30:27
Key Financial Figures
- $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
- $11.50 — Ordinary Share at an exercise price of $11.50 per share ZURAW The Nasdaq Stock Ma
Filing Documents
- tm2422831d1_8k.htm (8-K) — 31KB
- tm2422831d1_ex99-1.htm (EX-99.1) — 5KB
- tm2422831d1_ex99-1img001.jpg (GRAPHIC) — 3KB
- 0001104659-24-095960.txt ( ) — 258KB
- zura-20240903.xsd (EX-101.SCH) — 3KB
- zura-20240903_def.xml (EX-101.DEF) — 26KB
- zura-20240903_lab.xml (EX-101.LAB) — 36KB
- zura-20240903_pre.xml (EX-101.PRE) — 25KB
- tm2422831d1_8k_htm.xml (XML) — 5KB
01
Item 7.01 Regulation FD Disclosure. On September 3, 2024, Zura Bio Limited (" ZURA ", the " Company ") issued the press release attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD. The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated September 3, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZURA BIO LIMITED Date: September 3, 2024 By: /s/ Kim Davis Kim Davis Chief Legal Officer